Shares of Avinger Inc. (NASDAQ:AVGR) hit a new 52-week low during trading on Thursday . The company traded as low as $3.65 and last traded at $3.79, with a volume of 1,989,446 shares traded. The stock had previously closed at $4.62.

A number of analysts have commented on AVGR shares. Zacks Investment Research upgraded Avinger from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Canaccord Genuity reiterated a “buy” rating on shares of Avinger in a research report on Tuesday, July 12th. Finally, BTIG Research reiterated a “buy” rating and set a $18.00 target price on shares of Avinger in a research report on Friday, July 15th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $18.75.

The firm’s market capitalization is $47.00 million. The stock has a 50 day moving average of $7.46 and a 200-day moving average of $10.98.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings results on Monday, August 1st. The medical device company reported ($1.06) EPS for the quarter, topping the Zacks’ consensus estimate of ($1.15) by $0.09. The firm had revenue of $4.70 million for the quarter, compared to analyst estimates of $3.05 million. On average, equities analysts forecast that Avinger Inc. will post ($4.36) EPS for the current fiscal year.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.